Equillium, Inc. - Common Stock, $0.0001 Par Value (EQ)
CUSIP: 29446K106
Q1 2025 13F Holders as of 31 Mar 2025
- Type / Class
- Equity / Common Stock, $0.0001 Par Value
- Shares outstanding
- 63,261,075
- Total 13F shares
- 8,659,890
- Share change
- -44,872
- Total reported value
- $3,389,920
- Put/Call ratio
- 0.75%
- Price per share
- $0.39
- Number of holders
- 23
- Value change
- -$48,129
- Number of buys
- 8
- Number of sells
- 9
Quarterly Holders Quick Answers
What is CUSIP 29446K106?
CUSIP 29446K106 identifies EQ - Equillium, Inc. - Common Stock, $0.0001 Par Value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 29446K106:
Top shareholders of EQ - Equillium, Inc. - Common Stock, $0.0001 Par Value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Decheng Capital LLC |
13F
|
Company |
7%
|
4,447,308
|
$3,327,476 | — | 31 Dec 2024 | |
| TAKEDA PHARMACEUTICAL CO LTD |
13F
|
Company |
2.9%
|
1,824,977
|
$1,368,733 | — | 31 Dec 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.3%
|
841,948
|
$629,777 | — | 31 Dec 2024 | |
| Cota Capital Management, LLC |
13F
|
Company |
0.89%
|
562,278
|
$420,696 | — | 31 Dec 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.41%
|
261,400
|
$195,579 | — | 31 Dec 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.32%
|
204,385
|
$152,954 | — | 31 Dec 2024 | |
| Jason A. Keyes |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
126,633
|
$82,311 | — | 14 Feb 2025 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.17%
|
108,691
|
$80,000 | — | 31 Dec 2024 | |
| Callan Capital, LLC |
13F
|
Company |
0.16%
|
99,688
|
$74,587 | — | 31 Dec 2024 | |
| DCF Advisers, LLC |
13F
|
Company |
0.1%
|
62,947
|
$47,097 | — | 31 Dec 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.09%
|
59,720
|
$44,683 | — | 31 Dec 2024 | |
| Joel Rothman |
3/4/5
|
Chief Development Officer |
—
mixed-class rows
|
233,150
mixed-class rows
|
$33,727 | — | 02 Jan 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.07%
|
41,644
|
$31,158 | — | 31 Dec 2024 | |
| BlackRock, Inc. |
13F
|
Company |
0.06%
|
37,669
|
$28,184 | — | 31 Dec 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.06%
|
35,019
|
$26,201 | — | 31 Dec 2024 | |
| COMMONWEALTH EQUITY SERVICES, LLC |
13F
|
Company |
0.04%
|
25,000
|
$19,000 | — | 31 Dec 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.03%
|
19,754
|
$14,780 | — | 31 Dec 2024 | |
| UBS Group AG |
13F
|
Company |
0.03%
|
17,309
|
$12,947 | — | 31 Dec 2024 | |
| Virtu Financial LLC |
13F
|
Company |
0.02%
|
15,689
|
$12,000 | — | 31 Dec 2024 | |
| TWO SIGMA SECURITIES, LLC |
13F
|
Company |
0.02%
|
13,538
|
$10,129 | — | 31 Dec 2024 | |
| Corient Private Wealth LLC |
13F
|
Company |
0.02%
|
11,000
|
$8,231 | — | 31 Dec 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.01%
|
6,885
|
$5,151 | — | 31 Dec 2024 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
5,963
|
$4,460 | — | 31 Dec 2024 | |
| SIMPLEX TRADING, LLC |
13F
|
Company |
0%
|
2,090
|
$1,000 | — | 31 Dec 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
1,000
|
$748 | — | 31 Dec 2024 | |
| SBI Securities Co., Ltd. |
13F
|
Company |
0%
|
765
|
$572 | — | 31 Dec 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
145
|
$108 | — | 31 Dec 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
41
|
$31 | — | 31 Dec 2024 | |
| Ph.D. Yu Xu |
3/4/5
|
Director |
—
class O/S missing
|
20,000
|
— | — | 22 May 2024 |
Institutional Holders of Equillium, Inc. - Common Stock, $0.0001 Par Value (EQ) as of Q1 2025
As of 31 Mar 2025,
Equillium, Inc. - Common Stock, $0.0001 Par Value (EQ) was held by
23 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,659,890 shares.
The largest 10 holders included
Decheng Capital LLC, TAKEDA PHARMACEUTICAL CO LTD, VANGUARD GROUP INC, Cota Capital Management, LLC, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, ACADIAN ASSET MANAGEMENT LLC, Callan Capital, LLC, STATE STREET CORP, and CITADEL ADVISORS LLC.
This page lists
23
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2025 vs Q4 2024 Across Filers
Q4 2024 holders
25
Q1 2025 holders
23
Holder diff
-2
| Investor | Q4 2024 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q4 2024 Value $ | Q1 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.